Hugh J. Willison

18.8k total citations · 1 hit paper
193 papers, 9.8k citations indexed

About

Hugh J. Willison is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Hugh J. Willison has authored 193 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Neurology, 123 papers in Cellular and Molecular Neuroscience and 40 papers in Molecular Biology. Recurrent topics in Hugh J. Willison's work include Peripheral Neuropathies and Disorders (145 papers), Hereditary Neurological Disorders (114 papers) and Nerve injury and regeneration (42 papers). Hugh J. Willison is often cited by papers focused on Peripheral Neuropathies and Disorders (145 papers), Hereditary Neurological Disorders (114 papers) and Nerve injury and regeneration (42 papers). Hugh J. Willison collaborates with scholars based in United Kingdom, Netherlands and United States. Hugh J. Willison's co-authors include Bart C. Jacobs, Pieter A. van Doorn, Jaap J. Plomp, Graham M. O’Hanlon, Jennifer A. Veitch, John A. Goodfellow, Richard H. Quarles, Susan K. Halstead, Richard AC Hughes and Simon Rinaldi and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Hugh J. Willison

193 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guillain-Barré syndrome

2016 1.0k citations Hugh J. Willison, Bart C. Jacobs et al. The Lancet profile →

Peers

Countries citing papers authored by Hugh J. Willison

Since Specialization

Citations

This map shows the geographic impact of Hugh J. Willison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh J. Willison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh J. Willison more than expected).

Fields of papers citing papers by Hugh J. Willison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh J. Willison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh J. Willison. The network helps show where Hugh J. Willison may publish in the future.

Co-authorship network of co-authors of Hugh J. Willison

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh J. Willison. A scholar is included among the top collaborators of Hugh J. Willison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh J. Willison. Hugh J. Willison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inter‐Laboratory Validation of Nodal/Paranodal Antibody Testing 2025 ·Journal of the Peripheral Nervous System ·Cinta Lleixà, Maarten J. Titulaer, (unknown), (unknown), Susan K. Halstead, Janev Fehmi, Elba Pascual‐Goñi, (unknown), Luise Appeltshauser, (unknown), Manuela Paunovic, Patrick Waters, Hugh J. Willison, Claudia Sommer, Luís Querol, Ruth Huizinga, Kathrin Doppler, Simon Rinaldi	3
2	Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain‐Barré syndrome 2023 ·Journal of the Peripheral Nervous System ·(unknown), Rhona McGonigal, Jennifer A. Barrie, (unknown), Denggao Yao, Hugh J. Willison	9
3	Complement inhibition prevents glial nodal membrane injury in a GM1 antibody-mediated mouse model 2022 ·Brain Communications ·(unknown), Rhona McGonigal, Jennifer A. Barrie, (unknown), (unknown), (unknown), Denggao Yao, (unknown), Inge Van de Walle, Hugh J. Willison	13
4	Schwann cell nodal membrane disruption triggers bystander axonal degeneration in a Guillain-Barré syndrome mouse model 2022 ·Journal of Clinical Investigation ·Rhona McGonigal, (unknown), Jennifer A. Barrie, Denggao Yao, (unknown), (unknown), Simon Rinaldi, Edward G. Rowan, Hugh J. Willison	20
5	Zika Virus Infection Leads to Demyelination and Axonal Injury in Mature CNS Cultures 2021 ·Viruses ·Verena Schultz, (unknown), Quan Gu, Natasha Johnson, Claire L. Donald, (unknown), Jennifer A. Barrie, Ana da Silva Filipe, Christopher Linington, Hugh J. Willison, Julia M. Edgar, Susan C. Barnett, Alain Kohl	20
6	BAF45b Is Required for Efficient Zika Virus Infection of HAP1 Cells 2021 ·Viruses ·B. David Persson, (unknown), Richard Lindqvist, (unknown), Anna K. Överby, Alain Kohl, Hugh J. Willison, Annasara Lenman, Niklas Arnberg	2
7	Perisynaptic Schwann cells phagocytose nerve terminal debris in a mouse model of Guillain‐Barré syndrome 2020 ·Journal of the Peripheral Nervous System ·(unknown), (unknown), Sophie Robinson, Denggao Yao, Rhona McGonigal, Hugh J. Willison	26
8	Heparanase attenuates axon degeneration following sciatic nerve transection 2018 ·Scientific Reports ·(unknown), Rhona McGonigal, Hugh J. Willison, Susan C. Barnett	8
9	Anti-ganglioside Antibodies in Peripheral Nerve Pathology 2018 ·Methods in molecular biology ·Hugh J. Willison	9
10	Guillain-Barré syndrome breakdown → 2016 ·The Lancet ·Hugh J. Willison, Bart C. Jacobs, Pieter A. van Doorn	1021
11	Anti-ganglioside antibodies are removed from circulation in mice by neuronal endocytosis 2016 ·Brain ·(unknown), Rhona McGonigal, (unknown), Jennifer A. Barrie, Denggao Yao, Susan K. Halstead, Hugh J. Willison	26
12	The Diagnostic Utility of Determining Anti-GM1: GalC Complex Antibodies in Multifocal Motor Neuropathy: A Validation Study 2015 ·Journal of Neuromuscular Diseases ·(unknown), Lotte Vlam, Émilien Delmont, Susan K. Halstead, Leonard van den Berg, W. Ludo van der Pol, Hugh J. Willison	11
13	Neuronal Expression of GalNAc Transferase Is Sufficient to Prevent the Age-Related Neurodegenerative Phenotype of Complex Ganglioside-Deficient Mice 2014 ·Journal of Neuroscience ·Denggao Yao, Rhona McGonigal, Jennifer A. Barrie, (unknown), (unknown), (unknown), Simon Ngamli Fewou, Julia M. Edgar, Edward G. Rowan, Yuhsuke Ohmi, Keiko Furukawa, Koichi Furukawa, Peter Brophy, Hugh J. Willison	41
14	Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis 2011 ·Journal of Neuroimmunology ·Kathryn M. Brennan, (unknown), Simon Rinaldi, Colin O’Leary, Carl S. Goodyear, Gabriela Kalna, Ariel Arthur, (unknown), Sue Barnett, Christopher Linington, Jeffrey L. Bennett, Gregory P. Owens, Hugh J. Willison	63
15	Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions 2008 ·Journal of Cell Science ·Felipe A. Court, Thomas H. Gillingwater, (unknown), Diane L. Sherman, Kay N. Greenshields, A. Jennifer Morton, John B. Harris, Hugh J. Willison, Richard R. Ribchester	59
16	A pilot randomised, double blind, placebo controlled exploratory safety study of the use of interferon-beta 1a in the treatment of Guillain-Barre syndrome 2004 ·Journal of Neurology Neurosurgery & Psychiatry ·Richard AC Hughes, Jane Pritchard, (unknown), Zhannat Idrissova, (unknown), Ian Sutton, A V Swan, Hugh J. Willison, (unknown)	3
17	Complex Gangliosides as Autoantibody Targets at the Neuromuscular Junction in Miller Fisher Syndrome: A Current Perspective 2002 ·Neurochemical Research ·Graham M. O’Hanlon, Roland Bullens, Jaap J. Plomp, Hugh J. Willison	29
18	Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies 1998 ·Acta Neuropathologica ·Graham M. O’Hanlon, (unknown), Jennifer A. Veitch, (unknown), Hugh J. Willison	43
19	Muscle hypertrophy in multifocal motor neuropathy is associated with continuous motor unit activity 1997 ·Muscle & Nerve ·Colin O’Leary, (unknown), (unknown), Hugh J. Willison	25
20	Serum antibodies to gangliosides in guillain‐barré syndrome 1988 ·Annals of Neurology ·Amjad A. Ilyas, Hugh J. Willison, Richard H. Quarles, Firoze B. Jungalwala, David R. Cornblath, Bruce D. Trapp, Diane E. Griffin, John W. Griffin, Guy M. McKhann	224

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact